...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Carotid stenosis study
2
Feb 26, 2020 05:01PM
1
Feb 26, 2020 05:14PM

CS99   My understanding is that the following holds true:

Primary Endpoint: Narrowly Defined MACE  P-Value 0.11 with an 18% Hazard Reduction. (In accordance with Slide 8, Results Nov 18th, 2019)

 

Koo

6
Feb 26, 2020 05:41PM
5
Feb 27, 2020 10:37AM
Share
New Message
Please login to post a reply